https://scholars.lib.ntu.edu.tw/handle/123456789/460150
標題: | The potential of serum levels of soluble tumour necrosis factor receptor I as a biochemical marker in cervical cancer | 作者: | BOR-CHING SHEU HO-HSIUNG LIN DAW-YUAN CHANG HONG-NERNG HO Huang S.-C. |
公開日期: | 1997 | 卷: | 104 | 期: | 11 | 起(迄)頁: | 1314-1319 | 來源出版物: | BJOG: An International Journal of Obstetrics and Gynaecology | 摘要: | Objectives To investigate the significance of serum levels of soluble tumour necrosis factor receptor I (sTNF-RI) as a potential biochemical marker in women with cervical cancer. Design A prospective, case-controlled study. Participants Seventy-one women with cervical cancer and 33 women with myoma were enrolled in this study. Methods Pre-operative serum levels of sTNF-RI were measured with a standard enzyme-linked immunosorbent assay utilising murine monoclonal antibody against sTNF-RI. Main outcome measures All data in both groups were evaluated and correlated with the pre-operative serum levels of sTNF-RI. Data analysis was carried out using ANOVA with multiple comparison and linear regression. Results The mean serum level of sTNF-RI in the cervical cancer group was significantly lower than that in the myoma group (P < 0.001). The sTNF-RI levels decreased sequentially with disease progression from Stage Ia to IIb in women with cervical cancer. The mean serum level of sTNF-RI was also significantly lower in women with positive lymph node (P < 0.05) or recurrent cancer (P < 0.001). A negative correlation was observed between serum levels of sTNF-RI and tumour size (r=?0.622, P < 0.0001). Conclusions Decreased pre-operative serum levels of sTNF-RI are observed in women with cervical cancer. The results do not support that the use of sTNF-RI as a biochemical marker for cervical cancer. ? 1997 Wiley. All rights reserved. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/460150 | ISSN: | 1470-0328 | DOI: | 10.1111/j.1471-0528.1997.tb10981.x | SDG/關鍵字: | biochemical marker; tumor necrosis factor receptor; adult; article; blood level; cancer recurrence; controlled study; enzyme linked immunosorbent assay; female; human; major clinical study; priority journal; uterine cervix cancer; Adult; Case-Control Studies; Enzyme-Linked Immunosorbent Assay; Female; Humans; Leiomyoma; Middle Aged; Prospective Studies; Receptors, Tumor Necrosis Factor; Tumor Markers, Biological; Uterine Cervical Neoplasms; Uterine Neoplasms |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。